Switching to three pre-meal injections of insulin glulisine from the basal-bolus insulin therapy improves glycemic control in a patient with type 2 diabetes who had anti-insulin antibody

Hidekatsu Yanai, Taro Yoshimi, Hidetaka Hamasaki
  • International Journal of Diabetes in Developing Countries, September 2011, Springer Science + Business Media
  • DOI: 10.1007/s13410-011-0042-2

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Hidetaka Hamasaki

In partnership with: